Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10592560 | Bioorganic & Medicinal Chemistry Letters | 2012 | 4 Pages |
Abstract
A structure-activity relationship study was undertaken to address the lack of oral exposure of the H3 antagonist 1, which incorporated an arylketone. Among a number of sub-series, the 4H-pyrido[1,2-a]pyrimidin-4-one analog 21 showed an improved PK profile in rat and mouse and was active in an obesity model. The pyrimidin-4-one proved to be a novel and useful ketone bioisostere.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dong Xiao, Anandan Palani, Michael Sofolarides, Robert Aslanian, Robert E. Jr., Shirley M. Williams, Ren-Long Wu, Joyce Hwa, Christopher Sondey, Jean Lachowicz, Walter A. Korfmacher,